Prebiotics have moved from a niche ingredient category into mainstream conversation, but the clinical picture can be more nuanced. As the category expands, many clinicians aren’t yet up to speed on the differences between prebiotic types, or why a supplement might be needed over a food-first approach for the right patient or client.

In this session, Steve Imgrund, Communications Lead for the Global Prebiotic Association, is joined by Kara Siedman, RDN, CDCES (VP of Science and Partnerships, Resbiotic) and Lesli Bitel, MBA, RDN, LDN (business coach and strategist for nutrition and integrative health practitioners) for a conversation on current prebiotic science, how to vet products entering the market, and where prebiotics fit into clinical care, including for patients on GLP-1 medications.

What You’ll Learn:
– The current science behind prebiotics, and how their benefits extend well beyond gut health
– Established, novel, and emerging prebiotic ingredient classes, and why not all fiber is prebiotic, and not all prebiotics are fiber
– An overview of GPA’s Standards of Evidence, the pathway ingredients go through to be developed as evidence-based prebiotics, and why that matters for clinicians recommending these products
– How to vet a prebiotic product or company before recommending it
– How prebiotics fit into clinical care, including for patients on GLP-1 medications

Who Should Attend:
– Registered dietitians and nutritionists
– Integrative and functional medicine practitioners
– Clinical and outpatient care teams
– Anyone advising patients or clients on prebiotic or gut health strategies